Northwestern Mutual Wealth Management Co. Makes New $1.12 Million Investment in Humana Inc. $HUM

Northwestern Mutual Wealth Management Co. purchased a new stake in Humana Inc. (NYSE:HUM) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 2,824 shares of the insurance provider’s stock, valued at approximately $1,122,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Evolve Private Wealth LLC acquired a new position in shares of Humana during the second quarter worth about $278,000. Westpac Banking Corp acquired a new stake in Humana in the second quarter valued at approximately $230,000. William Blair Investment Management LLC purchased a new position in Humana in the second quarter worth approximately $13,569,000. Korea Investment CORP acquired a new position in Humana during the 2nd quarter worth approximately $34,579,000. Finally, EP Wealth Advisors LLC acquired a new position in Humana during the 2nd quarter worth approximately $276,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on HUM shares. Jefferies Financial Group upgraded shares of Humana from a “buy” rating to a “buy” rating in a report on Wednesday, May 20th. Guggenheim boosted their target price on shares of Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Piper Sandler raised Humana from a “hold” rating to an “overweight” rating and set a $463.00 target price on the stock in a report on Thursday, July 30th. Zacks Research cut Humana from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. Finally, Mizuho lifted their price target on Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Fourteen analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $403.91.

Humana Stock Performance

Shares of Humana stock opened at $388.92 on Wednesday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88. The firm’s 50 day moving average is $383.88 and its two-hundred day moving average is $285.00. The firm has a market capitalization of $46.70 billion, a P/E ratio of 36.79, a P/E/G ratio of 2.20 and a beta of 0.72.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter in the previous year, the firm earned $6.27 EPS. The company’s revenue was up 26.2% compared to the same quarter last year. Research analysts forecast that Humana Inc. will post 9.12 EPS for the current fiscal year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.